Showing results (131-140 of 1,928) with videos related to
Sort By:
Pageof 193
Hematology. American Society of Hematology. Education Program|December 10, 2017
AL amyloidosis: from molecular mechanisms to targeted therapiesGiampaolo MerliniHematology. American Society of Hematology. Education Program|December 10, 2017
Classification and risk assessment in AML: integrating cytogenetics and molecular profilingMatahi Moarii, Elli PapaemmanuilHematology. American Society of Hematology. Education Program|December 10, 2017
The role of targeted therapy in the management of patients with AMLAlexander E PerlHematology. American Society of Hematology. Education Program|December 10, 2017
When can we stop anticoagulation in patients with cancer-associated thrombosis?Agnes Y Y LeeHematology. American Society of Hematology. Education Program|December 10, 2017
Controversies in venous thromboembolism: to treat or not to treat superficial vein thrombosisJan Beyer-WestendorfHematology. American Society of Hematology. Education Program|December 10, 2017
Iron overload in thalassemia: different organs at different ratesAli T Taher, Antoine N SalibaHematology. American Society of Hematology. Education Program|December 10, 2017
New therapeutic targets in transfusion-dependent and -independent thalassemiaM Domenica Cappellini, Irene MottaHematology. American Society of Hematology. Education Program|December 10, 2017
Emerging role of novel therapies in Hodgkin lymphoma: proceed with cautionNancy L BartlettHematology. American Society of Hematology. Education Program|December 10, 2017
How should we sequence and combine novel therapies in CLL?Matthew S DavidsHematology. American Society of Hematology. Education Program|December 10, 2017
Follicular lymphoma: are we ready for a risk-adapted approach?Brad S KahlPageof 193